Drug recall · August 12, 2026
Cyclophosphamide for Injection recall
Why: Presence of Particulate Matter; identified as stainless steel
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1
- Lots / codes
Lot # C23019V1, Exp 10/31/2026; C24015V1, Exp 4/30/2027
- Quantity
- 4,077 vials
- Company
- Sunny Pharmtech Inc., Taoyuan City
- Distribution
- USA Nationwide
- Initiated
- July 17, 2026 · Voluntary: Firm initiated
- Classified
- August 7, 2026
- Reported
- August 12, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cyclophosphamide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.